THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 91 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q1 2014. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $78,000 | -31.0% | 199,100 | 0.0% | 0.00% | – |
Q1 2017 | $113,000 | +28.4% | 199,100 | 0.0% | 0.00% | – |
Q4 2016 | $88,000 | -34.8% | 199,100 | 0.0% | 0.00% | – |
Q3 2016 | $135,000 | +6.3% | 199,100 | 0.0% | 0.00% | – |
Q2 2016 | $127,000 | +38.0% | 199,100 | 0.0% | 0.00% | – |
Q1 2016 | $92,000 | -4.2% | 199,100 | 0.0% | 0.00% | – |
Q4 2015 | $96,000 | -88.1% | 199,100 | 0.0% | 0.00% | -100.0% |
Q3 2015 | $810,000 | +0.7% | 199,100 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $804,000 | +5.4% | 199,100 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $763,000 | 0.0% | 199,100 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $763,000 | +53.2% | 199,100 | +44.4% | 0.00% | 0.0% |
Q3 2014 | $498,000 | -8.8% | 137,900 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $546,000 | -9.9% | 137,900 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $606,000 | -4.3% | 137,900 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $633,000 | -2.5% | 137,900 | -1.2% | 0.00% | 0.0% |
Q3 2013 | $649,000 | -1.8% | 139,600 | +11.1% | 0.00% | 0.0% |
Q2 2013 | $661,000 | – | 125,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 393,000 | $1,556,000 | 1.48% |
FORTALEZA ASSET MANAGEMENT INC/ | 98,125 | $389,000 | 0.18% |
Rhenman & Partners Asset Management AB | 121,537 | $481,000 | 0.14% |
Baker Brothers Advisors | 1,826,358 | $7,232,000 | 0.09% |
Rotella Capital Management, Inc. | 21,600 | $86,000 | 0.07% |
SSI INVESTMENT MANAGEMENT LLC | 117,640 | $466,000 | 0.04% |
FEDERATED HERMES, INC. | 2,391,400 | $9,470,000 | 0.03% |
TFS CAPITAL LLC | 96,659 | $383,000 | 0.03% |
SMITH ASSET MANAGEMENT GROUP LP | 191,038 | $757,000 | 0.03% |
FRANKLIN STREET ADVISORS INC /NC | 28,000 | $111,000 | 0.02% |